Drugs / DC-CIK Immunotherapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01906632 | May 2013 → Dec 2022 | cancer | Capital Medical University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DC-CIK Immunotherapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01906632 ↗ |
| Modality | Cell therapy | “dendritic cells (DC) plus cytokine induced killer cells (CIK)” NCT01906632 ↗ |